Skip to main content



Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Preconference Workshops

Preconference Workshops

All Preconference workshops require a separate registration fee and are not included in main conference pricing. Learn more: https://www.raps.org/europe-2023/register

Preconference Workshops

  • Wednesday, May 10th
    08:00 – 16:00 CEST
    Be ready for EU CTR: Strategy, Systems and Lessons Learned
    Location: Saffron (1st fl)
    Workshop Leader: Carla Gomes – Thermo Fisher Clinical Research Group
    Presenter: Maria Alexandra Ribeiro – Portuguese National Ethics Committee for Clinical Research (CEIC)
    Presenter: Paolo Croce, PhD – PPD, part of Thermo Fisher Scientific
    Presenter: Eileen Smith, RA – PPD, part of Thermo Fisher Scientific
    Presenter: Rina Kacha – PPD, part of Thermo Fisher Scientific
    Preconference WorkshopPharmaceuticals
  • Wednesday, May 10th
    08:30 – 16:00 CEST
    Workshop: Global Regulatory CMC Strategies and Challenges for Biologicals
    Location: Lavender (1st floor)
    Workshop Leader: Neha Parashar, PMP – argenx
    Presenter: Ankit Geete – BioNTech, Germany
    Preconference WorkshopPharmaceuticals
  • Thursday, May 11th
    09:00 – 10:00 CEST
    Will the Revision of the EU general pharmaceuticals legislation deliver a world-class, future-proof medicines regulatory system for Europe? (Part 1)
    Location: Pearl 1
    Moderator & Presenter: Rebecca Lumsden, PhD – Sanofi
    Presenter: Francesca A. Day, PhD – European Medicines Agency
    Presenter: Julie Spony, MA – European Patients' Forum
    Presenter: Laetitia Szaller, MA – AM-Pharma
    Presenter: Fabio Datri, PhD – European Commission
    PharmaceuticalsDomain: Regulatory Frameworks & StrategyKnowledge Area: Regulatory Strategy Development
    Supported by 
  • Thursday, May 11th
    10:30 – 11:30 CEST
    Will the Revision of the EU general pharmaceuticals legislation deliver a world-class, future-proof medicines regulatory system for Europe?(Part 2 )
    Location: Pearl 1
    Moderator & Presenter: Rebecca Lumsden, PhD – Sanofi
    Presenter: Francesca A. Day, PhD – European Medicines Agency
    Presenter: Julie Spony, MA – European Patients' Forum
    Presenter: Fabio Datri, PhD – European Commission
    PharmaceuticalsDomain: Regulatory Frameworks & StrategyKnowledge Area: Regulatory Strategy Development
    Supported By
  • Thursday, May 11th
    11:45 – 12:45 CEST
    Making full use of early access and regultatory tools available to ATMPs
    Location: Carmine & Charcoal
    Moderator: Jennifer Neff, PhD – Sartorius Stedim Biotech GmbH
    Presenter: Paulette Robinson, Ph.D, RAC – Neurogene
    Presenter: Caroline Pothet – European Medicines Agency
    PharmaceuticalsDomain: Regulatory Frameworks & StrategyKnowledge Area: Process & Procedures
    Supported By
  • Thursday, May 11th
    13:45 – 14:45 CEST
    MDR Art. 117 for Combination Products After 2 years. Still the same? State of Play from EMA, NB and Industry
    Location: Pearl 2
    Moderator: Beate R. Schmidt, MSc, MDRA, RAC – Benefits Regulatory Consulting
    Presenter: Stephan Affolter – Ypsomed AG
    Presenter: Christiana Hofmann, PHD – anteris medical GmbH
    Presenter: Christelle Bouygues, PharmD – EMA
    Presenter: Theresa Jeary, BSc (Hons), MSc – BSI Group
    PharmaceuticalsDomain: Product Development & RegistrationKnowledge Area: Regulatory Guidance
    Supported By
  • Thursday, May 11th
    15:00 – 16:00 CEST
    Regulatory policies and guidelines – are these enabling timely development of Orphan medicines globally?
    Location: Pearl 1
    Moderator & Presenter: Magdalena Bujar, BSc, MSc, PhD – CIRS
    Presenter: Martine Zimmermann, PharmD – Ipsen Innovation
    Presenter: Kristina Larsson, MSc – European Medicines Agency
    PharmaceuticalsDomain: Regulatory Frameworks & StrategyKnowledge Area: Process & Procedures
    Supported By
  • Thursday, May 11th
    16:45 – 17:45 CEST
    EU Regulatory CMC Strategies and Challenges
    Location: Carmine & Charcoal
    Moderator & Presenter: Michael Craig, BSc Pharm MPSI – Parexel
    Presenter: Neha Parashar, PMP – argenx
    Presenter: Veronika Jekerle, PhD – European Medicines Agency
    PharmaceuticalsDomain: Business AcumenKnowledge Area: Industry-specific Knowledge
    Supported By
  • Friday, May 12th
    10:45 – 11:45 CEST
    EMA's PRIME Scheme in Review: Findings, Lessons Learnt and Future Directions
    Location: Pearl 2
    Moderator & Presenter: Kevin Cunningham, PhD – European Medicines Agency
    Presenter: Els Caenen, PharmD – Janssen Pharmaceutical Companies of Johnson & Johnson
    Presenter: Nadege Le Roux – Bristol-Myers Squibb
    Presenter: Ilona Reischl, PhD – Austrian Medicines Agency, AGES MEA
    PharmaceuticalsDomain: Regulatory Frameworks & StrategyKnowledge Area: Market Strategy
    Supported By
  • Friday, May 12th
    12:00 – 13:00 CEST
    Will Data-Driven Regulatory Science Stimulate Innovation and Initiate a New Regulatory Paradigm?
    Location: Carmine & Charcoal
    Moderator & Presenter: Rebecca Lumsden, PhD – Sanofi
    Presenter: Marjon Pasmooij – Medicines Evaluation Board
    Presenter: Frank Pétavy, MSc – European Medicines Agency
    PharmaceuticalsDomain: Business AcumenKnowledge Area: Project Management
    Supported By
  • Friday, May 12th
    14:00 – 15:00 CEST
    Strategic approaches in pregnancy and paediatrics: Is it time for a paradigm shift?
    Location: Pearl 1
    Moderator: Kate Stockman
    Moderator: Rüdiger Faust, PhD – UCB
    Presenter: Solange Corriol-Rohou, MD – AstraZeneca
    Presenter: Marie Teil, MD – UCB Pharma
    Presenter: Corinne de Vries, MA MSc PhD FISPE – European Medicines Agency
    PharmaceuticalsDomain: Product Development & RegistrationKnowledge Area: Regulatory Guidance
    Supported By
  • Friday, May 12th
    15:30 – 16:30 CEST
    European Expedited Approval Pathways in a Global Context
    Location: Carmine & Charcoal
    Moderator: Siegfried Schmitt, CSci CChem FRSC – Parexel
    Presenter: Yingying Liu – CSL Behring AG
    Presenter: Thomas Larsson, MSc, BSc – European Medicines Agency
    PharmaceuticalsDomain: Product Development & RegistrationKnowledge Area: Regulatory Guidance
    Supported By